The slip
PARKINSON RECEIPTno. 8819
24 Oct 2026, 16:38 UTCdopamine neurons, braak
predictionPPID in dopamine neurons tracks Braak Lewy-body stage
registered87f2c416debae911
discovery+0.56 p=0.115 n=9
replication+0.41 p=0.273 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.56, p 0.115)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT41e1f7b6e3d2a48d351f7432…
follows 5cfd570091df…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 8819: PPID in dopamine neurons, braak
- power
- full sample +0.52 (p 0.028, n 18), 95% CI +0.07 to +0.79. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: +0.48 (p 0.042, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.45 (p 0.059, n 18). could be the mix.
- skeptic
- leave-one-out range +0.45 to +0.59, sign flips 0; without severely affected donors +0.52 (p 0.028, n 18). robust.
- cell type
- strongest in astrocytes: +0.64 (p 0.0039, n 18) vs +0.52 in dopamine neurons. proposing astrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for PPID in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up PPID · astrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.57 p 0.041 (needs p < 2.4e-4)